Dec 6, 2022 7:00 am EST BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication
Dec 5, 2022 7:00 am EST BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease
Nov 29, 2022 11:20 am EST BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022
Nov 16, 2022 8:56 am EST BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
Oct 31, 2022 8:15 am EDT See What̢۪s Next For The Regenerative Medicine Field -- BioRestorative Intends to Lead The Pack In Stem Cell Therapies!
Oct 31, 2022 8:15 am EDT See What’s Next For The Regenerative Medicine Field -- BioRestorative Intends to Lead The Pack In Stem Cell Therapies!
Oct 20, 2022 9:30 am EDT BioRestorative Therapies CEO Lance Alstodt to be Interviewed on Famela and Friends Talk Radio Show
Oct 14, 2022 8:00 am EDT A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
Sep 28, 2022 7:00 am EDT BioRestorative Therapies to Present at the Dawson James Securities 7th Annual Small Cap Growth Conference